pfizer glp-1 news Pfizer, Innovent drugs pass China insurance preliminary review Pfizer picks GLP-1 candidate in

Biopharma PEG supplies polyethylene glycol (PEG) derivatives, monodisperse PEGs, custom PEG derivative synthesis and PEGylation services worldwide, from R&D through GMP commercial quantities, for preclinical, clinical trials, and commercial products for pharma, biotech, medical devices, and diagnostics

Designing and computational analyzing of chimeric long-lasting GLP-1 receptor agonists for type 2 diabetes

A study involving treatment up to 104 or 117 weeks in 134 patients with T2DM showed EX microspheres-nave patients experienced weight reductions of -2.7 kg (116)

Fewer studies have been carried out with DPP-4 inhibitors

N Engl J Med (2015) 372(14):133341

Glucagon-like-peptide-1 (GLP-1) agonists are a group of drugs approved for use in management of type-2 diabetes and obesity